Ontology highlight
ABSTRACT:
SUBMITTER: Guldvik IJ
PROVIDER: S-EPMC8303369 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
Guldvik Ingrid Jenny IJ Ekseth Lina L Kishan Amar U AU Stensvold Andreas A Inderberg Else Marit EM Lilleby Wolfgang W
Journal of personalized medicine 20210626 7
De novo metastatic or recurrence of prostate cancer (PC) remains life-threatening. Circulating tumor cells (CTCs) are noninvasive biomarkers and provide unique information that could enable tailored treatment. This study evaluated the impact of CTCs in PC patients eligible for peptide vaccine therapy. Twenty-seven patients were tested for CTCs with the CellCollector<sup>®</sup> device (Detector CANCER01(DC01)) during short-term androgen deprivation therapy (ADT) before cancer vaccine treatment ( ...[more]